Manulife (Manufacturers Life Insurance)
TXG icon

Manulife (Manufacturers Life Insurance)’s 10x Genomics TXG Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
55,533
+6,485
+13% +$170K ﹤0.01% 1581
2026
Q1 		$1.04M Buy
49,048
+1,661
+4% +$33.2K ﹤0.01% 1813
2025
Q4 		$773K Sell
47,387
-1,217
-3% -$18.4K ﹤0.01% 1984
2025
Q3 		$568K Sell
48,604
-3,704
-7% -$48.3K ﹤0.01% 2154
2025
Q2 		$606K Buy
52,308
+37,024
+242% +$337K ﹤0.01% 2080
2025
Q1 		$133K Sell
15,284
-73,536
-83% -$927K ﹤0.01% 2620
2024
Q4 		$1.28M Sell
88,820
-42,950
-33% -$678K ﹤0.01% 1782
2024
Q3 		$2.98M Sell
131,770
-10,053
-7% -$208K ﹤0.01% 1411
2024
Q2 		$2.76M Sell
141,823
-15,092
-10% -$395K ﹤0.01% 1395
2024
Q1 		$5.89M Buy
156,915
+42,869
+38% +$1.88M 0.01% 1114
2023
Q4 		$6.38M Buy
114,046
+16,019
+16% +$697K ﹤0.01% 1055
2023
Q3 		$4.04M Buy
98,027
+21,524
+28% +$1.12M ﹤0.01% 1202
2023
Q2 		$4.27M Sell
76,503
-4,811
-6% -$260K ﹤0.01% 1159
2023
Q1 		$4.54M Sell
81,314
-5,456
-6% -$255K ﹤0.01% 1131
2022
Q4 		$3.18M Sell
86,770
-5,466
-6% -$179K ﹤0.01% 1255
2022
Q3 		$2.76M Buy
92,236
+50,823
+123% +$1.94M ﹤0.01% 1295
2022
Q2 		$1.91M Buy
41,413
+9,194
+29% +$477K ﹤0.01% 1435
2022
Q1 		$2.41M Buy
32,219
+30,230
+1,520% +$2.64M ﹤0.01% 1454
2021
Q4 		$300K Sell
1,989
-20
-1% -$3.06K ﹤0.01% 2603
2021
Q3 		$292K Sell
2,009
-63,002
-97% -$10.8M ﹤0.01% 2690
2021
Q2 		$12.7M Buy
65,011
+437
+0.7% +$79.1K 0.01% 863
2021
Q1 		$11.7M Buy
64,574
+132
+0.2% +$22.8K 0.01% 882
2020
Q4 		$9.13M Buy
64,442
+52,166
+425% +$7.57M 0.01% 942
2020
Q3 		$1.53M Buy
+12,276
New +$1.29M ﹤0.01% 1505

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TXG Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its 10x Genomics (TXG) stake by 13% in Q2 2026, buying an estimated $170K and bringing the position to 55,533 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1581.

Manulife (Manufacturers Life Insurance) first reported a position in TXG in Q3 2020 and has held it in 24 quarters since. The position peaked at $12.7M in Q2 2021. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 55,533 shares of 10x Genomics worth $2.13M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 6,485 10x Genomics shares in Q2 2026, an estimated $170K.
  • 10x Genomics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1581 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in 10x Genomics in Q3 2020 and has held it in 24 quarters since.
  • Manulife (Manufacturers Life Insurance)'s 10x Genomics position peaked at $12.7M in Q2 2021.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.